Benefits of AstraZeneca Vaccine Outweigh Risks, Say EMA and WHO Officials – Urging Jabs to Continue as Safety Data Reviewed 12/03/2021 Madeleine Hoecklin Both the European Medicines Agency and the World Health Organization have urged that immunizations with the Oxford/AstraZeneca COVID-19 vaccine continue – despite a decision by several European countries to suspend its use – after reports of serious blood clots among 30 of the 5 million people vaccinated – leading to at least five deaths. An […] Continue reading -> Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Chinese Sinovac Vaccine Shows Reduced Efficacy Against SARS-CoV2 Variant Identified In Brazil – But AstraZeneca’s Holds Up Well – Early Data 08/03/2021 Madeleine Hoecklin The Chinese-developed “CoronaVac” vaccine against COVID-19 vaccine triggers a sixfold reduction in neutralizing antibody response against the P.1 variant first identified in Brazil, according to a pre-print study published last week, while the Oxford/AstraZeneca vaccine is likely effective against the variant of concern. These findings come as hospitals in northern Brazil are increasingly overwhelmed and […] Continue reading -> European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Medicines Agency Urges EU Member States To Postpone National Rollouts Of Russian Sputnik V Vaccine 08/03/2021 Madeleine Hoecklin A senior official at the European Medicines Agency (EMA) has cautioned EU member states to wait until the agency has reviewed the safety and efficacy data of Russia’s Sputnik V vaccine before granting the vaccine emergency use authorization at national level, and beginning mass rollouts. Last week, the EMA formally began a rolling review of […] Continue reading -> Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Group of Scientists Calls For Fresh Investigation Into Origins of SARS-CoV2 Virus 05/03/2021 Madeleine Hoecklin The WHO-convened international investigation into the origin of the SARS-CoV2 virus is too politically limited by China and lacks the mandate to yield fully independent conclusions about how the novel coronavirus emerged and infected humans, according to a group of prominent international scientists – who have called for a new, independent and “unrestricted” probe into […] Continue reading -> Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Johnson & Johnson’s One-Dose COVID Vaccine Approved By FDA, But Officials Warn That Initial Vaccine Rollout Could Be Uneven 01/03/2021 Madeleine Hoecklin & Kerry Cullinan The United States Food and Drug Administration (FDA) granted Johnson & Johnson’s single-dose COVID-19 vaccine emergency use authorization on Saturday, clearing the way for it to become the third COVID vaccine to be administered in the US starting on Tuesday. Initial supplies to the US market, however, are likely to be limited for at least […] Continue reading -> European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Union Moves Forward With Plans For Vaccine Passport By Summer; Experts Concerned About Practicality, Safety & Equity 28/02/2021 Madeleine Hoecklin Leaders of the 27 European Union member states are moving closer to a consensus on an EU-wide system of vaccine certificates for travel between countries in the bloc. Within three months a system will be introduced, EU officials announced on Thursday, the first day of the two-day virtual summit of the European Council. Several EU […] Continue reading -> New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Variant Detected in New York Could Pose Challenge For COVID Therapies and Vaccines 26/02/2021 Madeleine Hoecklin A new COVID-19 virus variant recently detected in New York is “surging alarmingly,” according to the authors of two new pre-print studies by two teams of US researchers, from Columbia University and the California Institute of Technology. Even worse, the new variant, dubbed B.1.526, shares some key mutations in its “spike” protein structure with several […] Continue reading -> ‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
‘Rapid Response Platforms’ Enabled COVID-19 Vaccine Development, Says Fauci 23/02/2021 Madeleine Hoecklin Rapid response platforms, particularly the messenger RNA (mRNA) platform, have changed the landscape of vaccine development, enabling the rapid response to the COVID-19 pandemic, said Dr Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID) on Monday. Fauci, speaking at the opening of the Global Vaccine and Immunization Research Forum (GVIRF), […] Continue reading -> EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
EU Cannot Sue AstraZeneca – Germany Commits to Sharing Doses 22/02/2021 Madeleine Hoecklin & Kerry Cullinan Threats from the European Commission to sue AstraZeneca over the delay in deliveries of COVID-19 vaccines hold no weight, according to the EU’s contract with the pharma company in which the right to sue was waived. Following the drugmaker’s announcement in late January of a 60% shortfall in vaccine deliveries for the first quarter after […] Continue reading -> US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
US & G7 Countries Make US$ 4.3 Billion In New Commitments To COVAX Global Vaccine Facility – Novavax To Provide 1.1 Billion Vaccine Doses 19/02/2021 Madeleine Hoecklin The United States is donating an additional US$2 billion to the COVAX facility over the next two years to facilitate the equitable distribution of COVID-19 vaccines to low- and middle-income countries, while the pharma company Novavax will provide a total of 1.1 billion doses of its vaccine to COVAX – a gesture that could increase […] Continue reading -> Posts navigation Older postsNewer posts